Novel deep-brain ‘superfiber’ could mean better Alzheimer’s imaging, diagnoses
By
Aaron Dorman
Dec 04, 2023
A novel “superfiber” could provide imaging of brain tissues in a less invasive way than conventional methods, researchers say.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer disease in 2050: experts
By
Kimberly Bonvissuto
Sep 15, 2021
Adopting an aggressive plan to reduce risk factors for Alzheimer’s disease and related dementias by 15% per decade could result in 1.2 million fewer people living with the disease in 2050, according...
More than ADLs: Assisted living now is about treatment, Silverado CEO says
By
Lois A. Bowers
Sep 30, 2024
Assisted living is a “whole different world” compared with 28 years ago, Silverado CEO Loren Shook told those attending a session at the National Investment Center for Seniors Housing & Care’s...
More news for Wednesday, Sept. 11
By
Kimberly Bonvissuto
Sep 11, 2024
Falling for financial scams might be early Alzheimer’s signal … New Mexico did not ensure attendants were qualified to provide personal care services: HHS OIG … Assisted living business director...
Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
Risk for Alzheimer’s dementia lower with treated versus untreated HTN
Aug 14, 2024
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
Plasma biomarkers of Alzheimer’s neuropathy linked to dementia risk
Aug 01, 2024
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.